Novel AI Blood Test Detects Liver Cancer
A new AI blood testing tech called DELFI successfully detected more than 80% of liver cancer cases in a new study.
Read MorePosted by Andy Lundin | Nov 18, 2022 | Unknown Origin & Other Cancer Types |
A new AI blood testing tech called DELFI successfully detected more than 80% of liver cancer cases in a new study.
Read MorePosted by Chris Wolski | Nov 18, 2022 | Diabetes & Metabolic Diseases |
NuraLogix has announced that its contactless health monitoring platform, Anura, will be able to assess metabolic and blood biomarker risks.
Read MorePosted by Andy Lundin | Nov 17, 2022 | Cardiovascular |
Clinicians who were high adopters of AI-enabled clinical decision support tools efficiently diagnosed low left ventricular ejection fraction.
Read MorePosted by Andy Lundin | Nov 16, 2022 | Prenatal Testing |
Sera Prognostics’ blood-based test offers individualized risk prediction for spontaneous preterm birth in asymptomatic singleton pregnancies.
Read MorePosted by Chris Wolski | Nov 14, 2022 | Diagnostic Technologies |
Clinical laboratory experts predict continued importance on COVID testing, ongoing technician shortages, and more in 2023.
Read More